University of Cologne clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 203 studies whose lead sponsor is University of Cologne. 26 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 6, 2026.
Keep track of what changes. Save the University of Cologne studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions University of Cologne leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 203. Browse all 203 →
- Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine Chest-CT ScanNot yet recruitingNCT07808593
- STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney DiseaseRecruitingNCT07280585Phase 3
- Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer PatientsNot yet recruitingNCT06414122Not applicable
- A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)Not yet recruitingNCT07699237Phase 2
- Vaccine-induced Immunity in Immunocompromised PatientsRecruitingNCT06612515
- Dietary Interventions During Living Kidney DonationsRecruitingNCT05709600Not applicable
- The German ADPKD Tolvaptan Treatment RegistryRecruitingNCT02497521
- Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm InfantsRecruitingNCT05975203Not applicable
- Leptospirosis Registry - LeptoScopeRecruitingNCT04288674
- Hantavirus Registry - HantaRegRecruitingNCT04323904
- Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte ChallengesRecruitingNCT06408077Not applicable
- Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational TrialRecruitingNCT05692726
- Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSLRecruitingNCT05583071Phase 2
- Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)Enrolling by invitationNCT06419179Phase 2
- Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin LymphomaNot yet recruitingNCT06919679Phase 2
- Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin LymphomaNot yet recruitingNCT06916416Phase 2
- Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin LymphomaNot yet recruitingNCT06045195Phase 2
- A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary TuberculosisRecruitingNCT06875336
- Trial Comparing Cataract Surgery with Triple-DMEK in Patients with Cataract and Fuchs Endothelial Corneal DystrophyRecruitingNCT06425666Not applicable
- Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-studyRecruitingNCT05969431
- Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin LymphomaRecruitingNCT04838652Phase 2
- IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer PatientsRecruitingNCT06496711Not applicable
- Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin LymphomaRecruitingNCT04837859Phase 2
- Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the PancreasRecruitingNCT04617457Phase 2
- ECMM Candida Registry - CandiRegRecruitingNCT03450005
- FungiScope - A Global Emerging Fungal Infection RegistryRecruitingNCT01731353
- Trial of a Voice-Based Generative AI Emotional Support CompanionCompletedNCT07860034Not applicable
- Artificial Intelligence(AI) in the Emergency Department (ED) in CologneActive, not recruitingNCT07725965
- Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Syndrome in Patients With Profound Hyponatremia in the Emergency DepartmentCompletedNCT06781710
- Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTPActive, not recruitingNCT04985318
- Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin LymphomaCompletedNCT03652441Phase 2
- Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First RelapseActive, not recruitingNCT04656951Phase 2
- Kidney in Coronavirus Disease 2019 RegistryCompletedNCT04797091
- Retrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound HyponatremiaCompletedNCT07255833
- Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic PurpuraCompletedNCT05876221
- Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access CapsCompletedNCT04534348
- Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 TherapyActive, not recruitingNCT03480334Phase 2
- Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin LymphomaCompletedNCT03004833Phase 2
- Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis PatientsCompletedNCT03350425
- Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German HospitalActive, not recruitingNCT06467877
- Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized SclerodermaCompletedNCT04200755Phase 2
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by InhalationTerminatedNCT04631705Phase 1/2
- Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint InhibitorsWithdrawnNCT03989050
- Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin LymphomaCompletedNCT02191930Phase 2
- Patient Empowerment for Major Surgery Preparation @ HomeCompletedNCT05167682
- Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)Active, not recruitingNCT05818449Not applicable
- HD21 for Advanced StagesActive, not recruitingNCT02661503Phase 3
- Metronomic Treatment in Children and Adolescents With Recurrent or Progressive High Risk NeuroblastomaCompletedNCT02641314Phase 2
- RICE: Radio-Immuno-Chemotherapy of Cancer of the EsophagusActive, not recruitingNCT04159974Phase 2
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by InfusionCompletedNCT04631666Phase 1/2